(Q40825395)

24 September 2017

Antimicrobial agents for the prevention and treatment of abdominal infections: a new generation? (English)

1 reference

24 September 2017

Rotstein OD

1

1 reference

PubMed ID

9935262

24 September 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

The American Journal of Surgery

24 September 2017

1 reference

24 September 2017

176

1 reference

24 September 2017

6A Suppl

1 reference

24 September 2017

80S-83S

1 reference

The bacteriology of intra-abdominal infections

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900021-5

Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900021-5

Antibiotic management of surgically treated gangrenous or perforated appendicitis. Comparison of gentamicin and clindamycin versus cefamandole versus cefoperazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900021-5

Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900021-5

Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900021-5

Bioavailability of oral ciprofloxacin in early postsurgical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900021-5

Parenteral and oral antibiotics in elective colon and rectal surgery. A prospective, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900021-5

Evaluation of new anti-infective drugs for the treatment of intraabdominal infections. Infectious Diseases Society of America and the Food and Drug Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900021-5

Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900021-5

Influence of low dose ciprofloxacin on microbial colonization of the digestive tract in healthy volunteers during normal and during impaired colonization resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900021-5

Mechanisms of microbial synergy in polymicrobial surgical infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2899%2900021-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9610(99)00021-5

1 reference

24 September 2017

1 reference

PubMed ID

9935262